Abstract
Highlights
This report:
- Decribes the major technologies for analyzing DNA in a clinic setting,
including DNA microarrays, PCR-based assays, ISH diagnostics, and LOAC
diagnostics
- Offers the current global market status for DNA diagnostics, with trends
and forecasts for growth over the next 5 years
- Analyzes differential applications within the categories of diagnostic
technologies
- Discusses government regulatory provisions that govern activities in the
industry
- Includes company profiles.
INTRODUCTION
STUDY GOALS AND OBJECTIVES
BCC' s goal in conducting this study is to determine the current status of the
DNA diagnostics industry and to assess its growth potential over a 5-year
period from 2008 to 2013. We are particularly interested in the markets for
DNA microarrays, PCR-based assays, fluorescent in situ hybridization, and
biochips.
In addition, we are interested in the market for DNA assays for specific
clinical applications. For each, we examine the technology, development
process, market penetration and the projected market for each diagnostic assay
through 2013.
Our key objective is to present a comprehensive analysis of the current market
and its future direction.
REASONS FOR DOING THE STUDY
DNA-based assays continue to move from research settings into the clinic and
as such they represent one of the fastest growing segments of diagnostics. We
are interested in the innovations in microarrays, PCR assays, biochips and
other common technologies for DNA detection as they are modified for routine
clinical use.
As nucleic acid testing becomes routine, a number of related issues have come
to the fore including government regulation, reimbursement through insurance,
patient confidentiality and other legal ramifications. These developments and
their impact on the DNA diagnostics business are also covered in this report.
SCOPE OF REPORT
This study examines the global market for assays used to detect specific
nucleic acid sequences in medical and life sciences applications. While the
goal of all DNA-based diagnostic assays is similar, several different
technologies can be employed. BCC analyzes each technology in detail and
determines major players, current market status and presents forecasts of
growth over the next 5 years. Scientific challenges and advances, including
the latest trends, are emphasized.
We examine government regulations, major collaborations, recent patents and
factors affecting the industry worldwide. In addition, we examine new
directions for DNA diagnostic technologies and emerging applications in
clinical diagnostics.
View Cart
